COMPANIES SELLING FLAVORED COFFEES
 

 

 

 

 

 

 

 

 

 

 

 

 

Thus, the company is working on new formulations for minoxidil, a baldness remedy, and other new products promoting hair growth with UpJohn. It joined with Syntex to market Aleve, a nonprescription version of Anaprox, an antiinflammatory drug that is popular with arthritis sufferers. It hopes to sell De-Nol, a gastrointestinal medicine made by Dutch drugmaker Gist-Brocades, as an ulcer treatment. It may use technology from Alcide, a Connecticut maker of disinfectants, in its toothpaste or mouthwash business. Finally, Procter & Gamble has an agreement with Triton Biosciences and Cetus to use Betaseron, a synthetic interferon, that it hopes will fight the common cold.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In this case, it was Procter & Gamble’s marketing strength that led it to enter the OTC drug industry. The opportunity was furnished by the environment—a concern for increasing health care costs—and many drug companies were glad to form alliances with this established OTC marketer. In recent years flavored coffees have become popular and companies like Starbucks have established a new style of coffee drinking. Considering this as an opportunity to expand, Dunkin’ Donuts expanded into coffee trendiness by offering four or more blends of fresh-brewed coffee, even hot and cold specialty drinks —all at a fraction of the Starbucks price. Value, together with no-nonsense service, has made Dunkin’ Donuts a favorable place for coffee lovers. To continue to ride on this opportunity, the chain has decided to be the latest in fast-food cool, offering in addition to specialty coffee, oven-baked bagels and fat-free muffins. In its redone stores, the tacky old pink décor is giving way to a more upscale “ripe raisin” hue. And not content to stop at morning munchies, the company has set its sights on the lunch crowd